Inflammation is a common element in the pathogenesis of most chronic liver diseases that
lead to fibrosis and cirrhosis. Inflammation is characterized by activation of innate immune …

As in previous years, the consensus group to consider the use of biological agents was
constituted by rheumatologists from the universities of Erlangen, Leiden and Vienna in …

Background Systemic-onset juvenile idiopathic arthritis does not always respond to
available treatments, including antitumour necrosis factor agents. We investigated the …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

Macrophage activation syndrome (MAS) is a phenomenon characterized by cytopenia,
organ dysfunction, and coagulopathy associated with an inappropriate activation of …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …

Macrophage-activation syndrome (MAS) is a potentially life-threatening complication of
systemic juvenile idiopathic arthritis (s-JIA). Tocilizumab (TCZ), a humanized anti-IL-6 …

Background A 13-year-old girl presented with features typical of systemic juvenile idiopathic
arthritis, including fever, rash and arthritis. Her past medical history was unremarkable …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 10th Annual Workshop on Advances in …

Background Macrophage activation syndrome (MAS) is a severe and potentially lethal
complication of several inflammatory diseases but seems particularly linked to systemic …